Webinars8.20.21

Patent Linkage Opens in China: Dispute Mechanisms and Enforcement Best Practices

pharmaceutical lab

China’s National Intellectual Property Administration (CNIPA) and National Medical Products Administration (NAMPA) recently promulgated a new final rule for disputes involving drug patents.

Keep Up to Date in a Changing World

Do you want to receive more valuable insights directly in your inbox? Visit our subscription center and let us know what you’re interested in learning more about.
Subscription Banner